Table 1.
Characteristics | All patients n=105 |
TLS negative n=72 |
TLS positive n=33 |
P value |
Sex, no (%) | 0.320 | |||
Male | 76 (72) | 50 (70) | 26 (79) | |
Female | 29 (28) | 22 (30) | 7 (21) | |
Age at surgery, no (%) | 0.160 | |||
<60 year | 52 (50) | 39 (54) | 13 (39) | |
>60 years | 53 (50) | 33 (46) | 20 (61) | |
Pathological T stage, no (%) | 0.362 | |||
pT1/2 | 64 (61) | 46 (64) | 18 (55) | |
pT3/4 | 41 (39) | 26 (36) | 15 (45) | |
Tumor grade, no (%) | 0.038 | |||
G1/2 | 69 (66) | 52 (72) | 17 (51) | |
G3/4 | 36 (34) | 20 (28) | 16 (49) | |
Venous invasion, no (%) | 0.465 | |||
Negative | 75 (71) | 53 (74) | 22 (67) | |
Positive | 30 (29) | 19 (26) | 11 (33) | |
Tumor size, no (%) | 0.264 | |||
<60 mm | 53 (50) | 39 (54) | 14 (42) | |
>60 mm | 52 (50) | 33 (46) | 19 (58) |
ccRCC, clear cell renal cell carcinoma; TLS, tertiary lymphoid structure.